Synthetic Cannabinoid WIN55,212-2 Caused Anxiety and Reduced Activity in Mice, With Female Mice Less Affected
Sub-chronic administration of the synthetic cannabinoid WIN55,212-2 produced dose-dependent anxiety and reduced locomotion in mice, with female mice less affected than males.
Quick Facts
What This Study Found
WIN55,212-2 produced dose-dependent anxiogenic effects and reduced locomotor activity, with female mice less compromised than males. GABA and glutamate levels increased significantly. No significant liver or kidney changes. CB1 receptor expression increased in both dose groups, with higher expression in female brains.
Key Numbers
40 mice (20M/20F). Two doses: 0.05 and 0.1 mg/kg. Dose-dependent anxiety and reduced locomotion. Significant GABA and glutamate increases. Female mice less behaviorally affected. Higher CB1 expression in female brains.
How They Did This
Controlled animal study with 40 adult mice randomized into four groups per sex: control, vehicle, low dose (0.05 mg/kg), and high dose (0.1 mg/kg). Assessed behavior, biochemistry, histopathology, and CB1 immunohistochemistry.
Why This Research Matters
Synthetic cannabinoids are far more potent than natural cannabis. This study shows even sub-chronic exposure produces measurable anxiety, neurochemical changes, and altered receptor expression, with important sex differences.
The Bigger Picture
The sex difference finding is notable because synthetic cannabinoid ER presentations skew heavily male. If females are biologically less affected at comparable doses, this could partially explain the gender gap.
What This Study Doesn't Tell Us
Animal study. Small group sizes (5 per group). Sub-chronic dosing does not capture chronic heavy use patterns. Only two doses tested.
Questions This Raises
- ?Do sex differences in synthetic cannabinoid response translate to humans?
- ?Does the increased CB1 expression in females represent a protective adaptation?
Trust & Context
- Key Stat:
- Female mice less behaviorally affected despite higher CB1 receptor expression
- Evidence Grade:
- Controlled animal study with appropriate design but small group sizes.
- Study Age:
- Published 2023.
- Original Title:
- Behavioral, biochemical and histopathological toxic profiles induced by sub-chronic cannabimimetic WIN55, 212-2 administration in mice.
- Published In:
- BMC pharmacology & toxicology, 24(1), 8 (2023)
- Database ID:
- RTHC-04823
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Are synthetic cannabinoids harmful even at low doses?
In this mouse study, even the lower dose produced anxiety, reduced activity, and neurochemical changes after sub-chronic exposure.
Do synthetic cannabinoids affect males and females differently?
Yes. Female mice showed less behavioral impairment than males despite higher CB1 receptor expression in the brain.
Read More on RethinkTHC
- THC-purity-potency-label-meaning
- dab-concentrate-addiction-withdrawal
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- healthiest-way-to-consume-cannabis
- how-cannabis-products-made-concentrates-edibles
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- sativa-vs-indica-difference-myth
- weed-potency-withdrawal
Cite This Study
https://rethinkthc.com/research/RTHC-04823APA
Omran, Ghada A; Abd Allah, Eman S H; Mohammed, Sherine Ahmed; El Shehaby, Doaa M. (2023). Behavioral, biochemical and histopathological toxic profiles induced by sub-chronic cannabimimetic WIN55, 212-2 administration in mice.. BMC pharmacology & toxicology, 24(1), 8. https://doi.org/10.1186/s40360-023-00644-3
MLA
Omran, Ghada A, et al. "Behavioral, biochemical and histopathological toxic profiles induced by sub-chronic cannabimimetic WIN55, 212-2 administration in mice.." BMC pharmacology & toxicology, 2023. https://doi.org/10.1186/s40360-023-00644-3
RethinkTHC
RethinkTHC Research Database. "Behavioral, biochemical and histopathological toxic profiles..." RTHC-04823. Retrieved from https://rethinkthc.com/research/omran-2023-behavioral-biochemical-and-histopathological
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.